STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF China202110772479.0Filed on 2015-05-27
Replication-Competent Adenovirus Type 4-HIV Env Vaccines And Their Use Read more about Replication-Competent Adenovirus Type 4-HIV Env Vaccines And Their Use Patent Cooperation TreatyPCT/US2021/045389Filed on 2021-08-10
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US Application 17/157,761Filed on 2021-01-25
LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS Read more about LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS Patent Cooperation TreatyPCT/US2021/036030Filed on 2021-06-04
Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza Read more about Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza Patent Cooperation TreatyPCT/US2021/032252Filed on 2021-05-13
TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS Read more about TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS Hong Kong62021032425.2Filed on 2019-02-19
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Eurasian Patent202191078Filed on 2016-10-24
NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US Application 17/358,522Filed on 2021-06-25
EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF Read more about EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF US Application 17/415,412Filed on 2021-06-17
Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof Read more about Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof European Patent19842479.8Filed on 2019-12-19